Katrin Ramsauer

发表

Ligand Binding TLR7 Abolishes Signaling without Affecting A Point Mutation in the Amino Terminus of

I. Leykin, B. Beutler, M. Mbow, 2011 .

Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase1

Julia Tischler, T. Decker, G. Egger, 2006, Molecular and Cellular Biology.

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

E. Reisinger, U. Wiedermann, A. Pfeiffer, 2018, The Lancet.

p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation

A. Porras, T. Decker, A. Nebreda, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Biodistribution and toxicology evaluation of a recombinant measles Schwarz‐based Lassa vaccine in cynomolgus macaques

W. P. Duprex, Roland Tschismarov, E. Tauber, 2022, Journal of applied toxicology : JAT.

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.

P. Desprès, Stephen J. Thomas, F. Tangy, 2015, The Lancet. Infectious diseases.

Antibody effector analysis of prime versus prime-boost immunizations with a recombinant measles-vectored chikungunya virus vaccine.

C. Mandl, E. Ooi, R. Zellweger, 2021, JCI insight.

Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons

T. Decker, M. Leitges, P. Kovarik, 2003, EMBO reports.

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections

Roland Tschismarov, E. Tauber, Katrin Ramsauer, 2020, Frontiers in Immunology.

Chikungunya Virus Vaccines: Viral Vector–Based Approaches

F. Tangy, K. Ramsauer, Katrin Ramsauer, 2016, The Journal of infectious diseases.

Specificity of signaling by STAT1 depends on SH2 and C‐terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression

D. Levy, T. Decker, Mathias Müller, 2001, The EMBO journal.

Induction of an IFN-Mediated Antiviral Response by a Self-Amplifying RNA Vaccine: Implications for Vaccine Design

Jason C Debasitis, J. Ulmer, A. Pulichino, 2017, The Journal of Immunology.

Implications for Vaccine Design Vaccine : Response by a Self-Amplifying RNA Induction of an IFN-Mediated Antiviral

J. Ulmer, A. Pulichino, Giulietta Maruggi, 2017 .

Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ-inducible gbp2 gene

H. Hauser, T. Decker, A. Kröger, 2007, Proceedings of the National Academy of Sciences.

The Stat1 Binding Motif of the Interferon-γ Receptor Is Sufficient to Mediate Stat5 Activation and Its Repression by SOCS3*

T. Decker, B. Rapp, Katrin Ramsauer, 2001, The Journal of Biological Chemistry.

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study

N. Escriou, H. Tabbal, Annette Martin, 2022, eBioMedicine.

Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial

K. Russell, Wen Liu, Keith Boundy, 2022, eBioMedicine.

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates

E. Wang, S. Weaver, Sasha R. Azar, 2019, The Journal of infectious diseases.

Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya

F. Tangy, P. N. Frantz, C. Gerke, 2019, Expert review of vaccines.

Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity.

K. Pfeffer, T. Decker, Mathias Müller, 2003, Immunity.

Phase 2 clinical results: Chikungunya vaccine based on measles vector (MV-CHIK) induces humoral and cellular responses in the presence of pre-existing anti measles immunity

E. Reisinger, M. Müllner, J. Aberle, 2019, International Journal of Infectious Diseases.

A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding

I. Leykin, B. Beutler, M. Mbow, 2011, The Journal of Immunology.

Immunogenicity, safety, and tolerability of a recombinant measles-vectored Lassa fever vaccine: a randomised, placebo-controlled, first-in-human trial

M. Mateo, S. Baize, P. Damme, 2023, The Lancet.